Last $30.35 USD
Change Today -0.22 / -0.72%
Volume 166.9K
RLYP On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Scott M. Rocklage Ph.D.

Former Executive Chairman and Member of Nominating & Corporate Governance Committee, Relypsa, Inc.
AgeTotal Calculated CompensationThis person is connected to 57 board members in 6 different organizations across 11 different industries.

See Board Relationships
60--

Background*

Dr. Scott M. Rocklage, Ph.D. has been a Managing Partner at 5AM Venture Management LLC since 2004. Dr. Rocklage joined 5AM Ventures in 2003 as a Venture Partner. He was the Chief Executive Officer and President at Amersham Health. He served as an Executive Chairman and Co-President at Ilypsa, Inc. Dr. Rocklage served as President of Cubist Pharmaceuticals Inc from July 1994 to March 2001 and its Founding Chief Executive Officer from July 1994 to June 2003. He served ...

Read Full Background

Corporate Headquarters*

700 Saginaw Drive
Redwood City, California 94063

United States

Phone: 650-421-9500
Fax: --

Board Members Memberships*

Former Director
Executive Chairman
Former Executive Chairman and Co-President
Director
Former Director
Chairman
Chairman
Director
Chairman
1994-2004
Former Chairman
2004-Present
Director, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee
2007-2014
Former Executive Chairman and Member of Nominating & Corporate Governance Committee
2014-Present
Director

Education*

Doctorate
Massachusetts Institute of Technology
Bachelor's Degree
University of California Berkeley

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RLYP:US $30.35 USD -0.22

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RELYPSA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.